ROCK2 and cholangiocarcinoma: Furthermore, the results of western blotting and real-time quantitative reverse transcription PCR (qRT-PCR) analyses revealed ROCK2 as highly expressed in Pemigatinib-resistant CCA cells (Fig. 1D, E).